KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Invested Capital (2019 - 2026)

GoodRx Holdings' Invested Capital history spans 7 years, with the latest figure at $1.1 billion for Q4 2025.

  • On a quarterly basis, Invested Capital fell 8.64% to $1.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 billion, a 8.64% decrease, with the full-year FY2025 number at $1.1 billion, down 8.64% from a year prior.
  • Invested Capital hit $1.1 billion in Q4 2025 for GoodRx Holdings, up from $1.1 billion in the prior quarter.
  • Over the last five years, Invested Capital for GDRX hit a ceiling of $1.6 billion in Q2 2023 and a floor of $756.1 million in Q1 2021.
  • Historically, Invested Capital has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2025.
  • Biggest five-year swings in Invested Capital: surged 180.98% in 2021 and later decreased 22.72% in 2024.
  • Tracing GDRX's Invested Capital over 5 years: stood at $838.7 million in 2021, then soared by 75.7% to $1.5 billion in 2022, then dropped by 3.75% to $1.4 billion in 2023, then fell by 14.25% to $1.2 billion in 2024, then fell by 8.64% to $1.1 billion in 2025.
  • Business Quant data shows Invested Capital for GDRX at $1.1 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.